Chiasma Inc. (CHMA) NASDAQ
$3.76 - (-)
Market Cap: -
As of 08/05/21 12:00 AM EDT. Market closed.
Chiasma Inc. (CHMA)
NASDAQ
$3.76
- (-)
Market Cap: -
As of 08/05/21 12:00 AM EDT. Market closed.
Add to Portfolio
Chiasma is a commercial-stage biopharmaceutical company focused on developing and commercializing oral therapies to improve the lives of patients who face challenges associated with their existing treatments for rare and serious chronic diseases. Employing its Transient Permeability Enhancer (TPE®) technology platform, Chiasma seeks to develop oral medications that are currently available only ... read more
Chiasma is a commercial-stage biopharmaceutical company focused on developing and commercializing oral therapies to improve the lives of patients who face challenges associated with their existing treatments for rare and serious chronic diseases. Employing its Transient Permeability Enhancer (TPE®) technology platform, Chiasma seeks to develop oral medications that are currently available only as injections. In June 2020, Chiasma received FDA approval of MYCAPSSA for long-term maintenance therapy in acromegaly patients who have responded to and tolerated treatment with octreotide or lanreotide. MYCAPSSA, the first and only oral somatostatin analog approved by the FDA, is available for commercial sale. Chiasma is headquartered in Needham, MA with a wholly owned subsidiary in Israel. MYCAPSSA, TPE and CHIASMA are registered trademarks of Chiasma. read less
COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Raj Kannan
Full Time Employees
85
CEO Compensation (Base)
$500,000
CEO Compensation (Total)
$1.04M
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Raj Kannan
Full Time Employees
85
CEO Compensation (Base)
$500,000
CEO Compensation (Total)
$1.04M
Address
140 Kendrick Street, Building C East, Massachusetts, Needham, 02494.
PRICE CHART FOR CHIASMA INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$3.76
Previous Close
$3.76
Days Range
$3.76 - $4.10
52 week range
- - -
Volume
8,196,718
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
57,894,177
Open
$3.76
Previous Close
$3.76
Days Range
$3.76 - $4.10
52 week range
- - -
Volume
8,196,718
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
57,894,177
FINANCIAL STATEMENTS FOR CHIASMA INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR CHIASMA INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Mamluk Roni | Director | Feb 09, 2021 | Option Exercise | $1.85 | 27,981 | 51,765 | 27,981 | Feb 11, 2021, 05:39 PM |
| Mamluk Roni | Director | Feb 09, 2021 | Sale | $5.00 | 27,981 | 139,905 | 0 | Feb 11, 2021, 05:39 PM |
| Fitzpatrick Mark J. | President | Dec 04, 2020 | Option Exercise | $2.60 | 10,000 | 26,000 | 19,612 | Dec 07, 2020, 04:35 PM |
| STACK DAVID M | Director | Nov 30, 2020 | Buy | $4.27 | 25,000 | 106,858 | 25,000 | Dec 01, 2020, 07:40 PM |
| KANNAN RAJ | Chief Executive Officer | Nov 23, 2020 | Buy | $4.00 | 120,000 | 480,492 | 137,095 | Nov 24, 2020, 06:01 PM |
| KANNAN RAJ | Chief Executive Officer | Jul 14, 2020 | Buy | $4.20 | 10,000 | 42,000 | 17,095 | Jul 15, 2020, 06:57 PM |
| Mamluk Roni | Director | Feb 20, 2020 | Option Exercise | $0.09 | 82,186 | 7,397 | 82,186 | Feb 21, 2020, 04:43 PM |
| Mamluk Roni | Director | Feb 20, 2020 | Sale | $4.54 | 82,186 | 373,124 | 0 | Feb 21, 2020, 04:43 PM |
| Mamluk Roni | Director | Dec 20, 2019 | Option Exercise | $0.09 | 61,139 | 5,503 | 61,139 | Dec 23, 2019, 04:10 PM |
| Mamluk Roni | Director | Dec 20, 2019 | Sale | $5.51 | 61,139 | 336,876 | 0 | Dec 23, 2019, 04:10 PM |
| Mamluk Roni | Director | Oct 16, 2019 | Option Exercise | $0.09 | 10,000 | 900 | 10,000 | Oct 17, 2019, 08:23 PM |
| Mamluk Roni | Director | Oct 16, 2019 | Sale | $4.94 | 10,000 | 49,400 | 0 | Oct 17, 2019, 08:23 PM |
| LUDLAM WILLIAM | See Remarks | Sep 27, 2019 | Buy | $4.91 | 5,050 | 24,783 | 11,799 | Sep 27, 2019, 05:34 PM |
| Mamluk Roni | Director | Sep 20, 2019 | Option Exercise | $0.09 | 50,000 | 4,500 | 50,000 | Sep 23, 2019, 04:08 PM |
| Mamluk Roni | Director | Sep 20, 2019 | Sale | $5.59 | 50,000 | 279,500 | 0 | Sep 23, 2019, 04:08 PM |
| Minick Scott | Director | Aug 20, 2019 | Buy | $5.33 | 5,518 | 29,411 | 87,194 | Aug 21, 2019, 04:16 PM |
| Minick Scott | Director | Aug 19, 2019 | Buy | $5.02 | 4,300 | 21,586 | 81,676 | Aug 21, 2019, 04:16 PM |
| Mamluk Roni | Director | Jul 16, 2019 | Option Exercise | $0.09 | 10,000 | 900 | 10,000 | Jul 17, 2019, 07:40 PM |
| Mamluk Roni | Director | Jul 16, 2019 | Sale | $6.35 | 10,000 | 63,500 | 0 | Jul 17, 2019, 07:40 PM |
| Mamluk Roni | Director | Apr 16, 2019 | Option Exercise | $0.09 | 10,000 | 900 | 10,000 | Apr 17, 2019, 05:19 PM |
| Mamluk Roni | Director | Apr 16, 2019 | Sale | $5.31 | 10,000 | 53,100 | 0 | Apr 17, 2019, 05:19 PM |
| LUDLAM WILLIAM | See Remarks | Apr 01, 2019 | Buy | $5.00 | 1,625 | 8,125 | 6,749 | Apr 02, 2019, 06:49 PM |
| Mamluk Roni | Director | Mar 05, 2019 | Option Exercise | $0.09 | 5,000 | 450 | 5,000 | Mar 06, 2019, 04:34 PM |
| Mamluk Roni | Director | Mar 05, 2019 | Sale | $5.00 | 5,000 | 25,000 | 0 | Mar 06, 2019, 04:34 PM |
| Mamluk Roni | Director | Jan 22, 2019 | Option Exercise | $0.09 | 5,000 | 450 | 5,000 | Jan 23, 2019, 05:43 PM |
| Mamluk Roni | Director | Jan 22, 2019 | Sale | $3.67 | 5,000 | 18,370 | 0 | Jan 23, 2019, 05:43 PM |
| Fitzpatrick Mark J. | President and CEO | Dec 20, 2018 | Buy | $2.50 | 9,612 | 24,030 | 9,612 | Dec 21, 2018, 02:03 PM |
| Minick Scott | Director | Sep 20, 2018 | Buy | $3.09 | 13,000 | 40,170 | 84,220 | Sep 20, 2018, 09:21 PM |
| Minick Scott | Director | Sep 19, 2018 | Buy | $3.06 | 8,000 | 24,480 | 71,220 | Sep 20, 2018, 09:21 PM |
| Minick Scott | Director | Sep 18, 2018 | Buy | $3.07 | 4,000 | 12,280 | 63,220 | Sep 20, 2018, 09:21 PM |
| Mamluk Roni | Director | Jun 18, 2018 | Option Exercise | $0.09 | 2,389 | 215 | 2,389 | Jun 20, 2018, 05:19 PM |
| Mamluk Roni | Director | Jun 18, 2018 | Sale | $1.46 | 2,389 | 3,484 | 0 | Jun 20, 2018, 05:19 PM |
| Mamluk Roni | Director | Mar 19, 2018 | Option Exercise | $0.09 | 2,389 | 215 | 2,389 | Mar 20, 2018, 04:32 PM |
| Mamluk Roni | Director | Mar 19, 2018 | Sale | $1.53 | 2,389 | 3,655 | 0 | Mar 20, 2018, 04:32 PM |
| Mamluk Roni | Director | Dec 18, 2017 | Option Exercise | $0.09 | 2,389 | 215 | 2,389 | Dec 19, 2017, 04:33 PM |
| Mamluk Roni | Director | Dec 18, 2017 | Sale | $1.75 | 2,389 | 4,181 | 0 | Dec 19, 2017, 04:33 PM |
| Mamluk Roni | Director | Oct 24, 2017 | Option Exercise | $0.09 | 2,389 | 215 | 2,389 | Oct 26, 2017, 04:06 PM |
| Mamluk Roni | Director | Oct 24, 2017 | Sale | $2.27 | 2,389 | 5,430 | 0 | Oct 26, 2017, 04:06 PM |
| Minick Scott | Director | Sep 21, 2017 | Buy | $2.36 | 10,000 | 23,569 | 59,220 | Sep 22, 2017, 04:42 PM |
| Minick Scott | Director | Sep 20, 2017 | Buy | $2.38 | 15,000 | 35,690 | 49,220 | Sep 22, 2017, 04:42 PM |
| 7-MED Health Ventures LP | 10% Owner | Jul 21, 2015 | Buy | $16.00 | 93,750 | 1,500,000 | 93,750 | Jul 23, 2015, 05:45 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Mamluk Roni | Director | 02/09/2021 | 51,765 |
| Mamluk Roni | Director | 02/09/2021 | 139,905 |
| Fitzpatrick Mark J. | President | 12/04/2020 | 26,000 |
| STACK DAVID M | Director | 11/30/2020 | 106,858 |
| KANNAN RAJ | Chief Executive Officer | 11/23/2020 | 480,492 |
| KANNAN RAJ | Chief Executive Officer | 07/14/2020 | 42,000 |
| Mamluk Roni | Director | 02/20/2020 | 7,397 |
| Mamluk Roni | Director | 02/20/2020 | 373,124 |
| Mamluk Roni | Director | 12/20/2019 | 5,503 |
| Mamluk Roni | Director | 12/20/2019 | 336,876 |
| Mamluk Roni | Director | 10/16/2019 | 900 |
| Mamluk Roni | Director | 10/16/2019 | 49,400 |
| LUDLAM WILLIAM | See Remarks | 09/27/2019 | 24,783 |
| Mamluk Roni | Director | 09/20/2019 | 4,500 |
| Mamluk Roni | Director | 09/20/2019 | 279,500 |
| Minick Scott | Director | 08/20/2019 | 29,411 |
| Minick Scott | Director | 08/19/2019 | 21,586 |
| Mamluk Roni | Director | 07/16/2019 | 900 |
| Mamluk Roni | Director | 07/16/2019 | 63,500 |
| Mamluk Roni | Director | 04/16/2019 | 900 |
| Mamluk Roni | Director | 04/16/2019 | 53,100 |
| LUDLAM WILLIAM | See Remarks | 04/01/2019 | 8,125 |
| Mamluk Roni | Director | 03/05/2019 | 450 |
| Mamluk Roni | Director | 03/05/2019 | 25,000 |
| Mamluk Roni | Director | 01/22/2019 | 450 |
| Mamluk Roni | Director | 01/22/2019 | 18,370 |
| Fitzpatrick Mark J. | President and CEO | 12/20/2018 | 24,030 |
| Minick Scott | Director | 09/20/2018 | 40,170 |
| Minick Scott | Director | 09/19/2018 | 24,480 |
| Minick Scott | Director | 09/18/2018 | 12,280 |
| Mamluk Roni | Director | 06/18/2018 | 215 |
| Mamluk Roni | Director | 06/18/2018 | 3,484 |
| Mamluk Roni | Director | 03/19/2018 | 215 |
| Mamluk Roni | Director | 03/19/2018 | 3,655 |
| Mamluk Roni | Director | 12/18/2017 | 215 |
| Mamluk Roni | Director | 12/18/2017 | 4,181 |
| Mamluk Roni | Director | 10/24/2017 | 215 |
| Mamluk Roni | Director | 10/24/2017 | 5,430 |
| Minick Scott | Director | 09/21/2017 | 23,569 |
| Minick Scott | Director | 09/20/2017 | 35,690 |
| 7-MED Health Ventures LP | 10% Owner | 07/21/2015 | 1,500,000 |
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR CHIASMA INC
LOADING...